# Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)

Study · id `cardio:ct-nct02237495` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02237495](<https://clinicaltrials.gov/study/NCT02237495>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02237495

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1100 participants.

## Technical summary

Registry record NCT02237495. Randomized; double masking; primary purpose prevention. Start 2014-04-09 (actual); primary completion 2017-03-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 1100 participants (enrolled count; ClinicalTrials.gov record NCT02237495, source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)
- Started: 2014-04-09 (actual) (ClinicalTrials.gov record NCT02237495, source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)
- Primary completion: 2017-03-01 (actual) (ClinicalTrials.gov record NCT02237495, source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)
- Completion: 2018-03 (actual) (ClinicalTrials.gov record NCT02237495, source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02237495, source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02237495-2020-07-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
- Acronym: DOCS
- Condition: Heart Valve Diseases
- Condition: Coronary Artery Disease
- Intervention (Drug): dexmedetomidine
- Intervention (Drug): placebo
- Lead sponsor: Xijing Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Xijing Hospital (`cardio:org-xijing-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Dexmedetomidine on Outcomes After Cardiac Surgery (DOCS): a randomised double-blind, placebo-controlled trial (`cardio:pubmed-41238464`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ea0883adaa4f1ac9002ed2a6c6e04a6c2aedefc6e1eb51e248c1541200bb6dc6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
